UroGen Announces $120M Private Placement Of 12,579,156 Shares At $9.54/Share
Portfolio Pulse from Benzinga Newsdesk
UroGen Pharma Ltd. has announced a private placement of 12,579,156 shares at $9.54 per share, raising $120 million in capital.
July 27, 2023 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UroGen's private placement of over 12.5 million shares at $9.54 per share could dilute existing shareholders' equity, potentially leading to a short-term decrease in stock price.
Private placements often lead to dilution of existing shareholders' equity, which can result in a decrease in stock price. Given the size of this placement, the impact could be significant.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100